{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    26,
    27,
    28
  ],
  "modelUsed": "claude-opus-4-5",
  "studyDesignStructure": {
    "studyArms": [
      {
        "id": "arm_1",
        "name": "Cohort A",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Participants receive subcutaneous ramucirumab to evaluate PK and safety"
      },
      {
        "id": "arm_2",
        "name": "Sub-Cohort B1",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Participants receive subcutaneous ramucirumab at a second dose level to generate PK data to inform dosing strategy for Sub-Cohort B2"
      },
      {
        "id": "arm_3",
        "name": "Sub-Cohort B2",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Participants receive subcutaneous ramucirumab with loading dose and maintenance weekly dose based on Sub-Cohort B1 results"
      },
      {
        "id": "arm_4",
        "name": "Sub-Cohort B3",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Participants receive subcutaneous ramucirumab with dose that may be adjusted"
      },
      {
        "id": "arm_5",
        "name": "Cohort C",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Participants receive subcutaneous ramucirumab alone or in combination with additional anti-cancer therapy"
      }
    ],
    "studyCells": [
      {
        "id": "cell_1",
        "armId": "arm_1",
        "epochId": "epoch_1",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_2",
        "armId": "arm_1",
        "epochId": "epoch_2",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_3",
        "armId": "arm_1",
        "epochId": "epoch_3",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_4",
        "armId": "arm_2",
        "epochId": "epoch_1",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_5",
        "armId": "arm_2",
        "epochId": "epoch_2",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_6",
        "armId": "arm_2",
        "epochId": "epoch_3",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_7",
        "armId": "arm_3",
        "epochId": "epoch_1",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_8",
        "armId": "arm_3",
        "epochId": "epoch_2",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_9",
        "armId": "arm_3",
        "epochId": "epoch_3",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_10",
        "armId": "arm_4",
        "epochId": "epoch_1",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_11",
        "armId": "arm_4",
        "epochId": "epoch_2",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_12",
        "armId": "arm_4",
        "epochId": "epoch_3",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_13",
        "armId": "arm_5",
        "epochId": "epoch_1",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_14",
        "armId": "arm_5",
        "epochId": "epoch_2",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_15",
        "armId": "arm_5",
        "epochId": "epoch_3",
        "elementIds": [],
        "instanceType": "StudyCell"
      }
    ],
    "studyCohorts": [
      {
        "id": "cohort_1",
        "name": "Cohort A",
        "instanceType": "StudyCohort",
        "characteristic": "Initial cohort for PK and safety evaluation of SC ramucirumab"
      },
      {
        "id": "cohort_2",
        "name": "Cohort B",
        "instanceType": "StudyCohort",
        "characteristic": "Expansion cohort to investigate additional dosing regimens, comprising Sub-Cohorts B1, B2, and B3"
      },
      {
        "id": "cohort_3",
        "name": "Cohort C",
        "instanceType": "StudyCohort",
        "characteristic": "Cohort for SC ramucirumab alone or in combination with additional anti-cancer therapy"
      }
    ],
    "summary": {
      "armCount": 5,
      "cellCount": 15,
      "cohortCount": 3
    },
    "studyDesign": {
      "id": "sd_1",
      "name": "Study Design",
      "instanceType": "InterventionalStudyDesign",
      "trialIntentTypes": [
        {
          "code": "Treatment",
          "codeSystem": "USDM",
          "decode": "Treatment"
        }
      ],
      "trialType": {
        "code": "Interventional",
        "codeSystem": "USDM",
        "decode": "Interventional"
      },
      "blindingSchema": {
        "code": "Open Label",
        "codeSystem": "USDM",
        "decode": "Open Label"
      },
      "randomizationType": {
        "code": "Non-Randomized",
        "codeSystem": "USDM",
        "decode": "Non-Randomized"
      },
      "armIds": [
        "arm_1",
        "arm_2",
        "arm_3",
        "arm_4",
        "arm_5"
      ],
      "cohortIds": [
        "cohort_1",
        "cohort_2",
        "cohort_3"
      ],
      "therapeuticAreas": [
        "Oncology"
      ]
    }
  },
  "rawResponse": {
    "studyDesign": {
      "type": "Interventional",
      "trialIntentTypes": [
        "Treatment"
      ],
      "blinding": {
        "schema": "Open Label",
        "maskedRoles": []
      },
      "randomization": {
        "type": "Non-Randomized",
        "allocationRatio": null,
        "stratificationFactors": []
      },
      "controlType": null,
      "therapeuticAreas": [
        "Oncology"
      ]
    },
    "arms": [
      {
        "name": "Cohort A",
        "type": "Experimental Arm",
        "description": "Participants receive subcutaneous ramucirumab to evaluate PK and safety"
      },
      {
        "name": "Sub-Cohort B1",
        "type": "Experimental Arm",
        "description": "Participants receive subcutaneous ramucirumab at a second dose level to generate PK data to inform dosing strategy for Sub-Cohort B2"
      },
      {
        "name": "Sub-Cohort B2",
        "type": "Experimental Arm",
        "description": "Participants receive subcutaneous ramucirumab with loading dose and maintenance weekly dose based on Sub-Cohort B1 results"
      },
      {
        "name": "Sub-Cohort B3",
        "type": "Experimental Arm",
        "description": "Participants receive subcutaneous ramucirumab with dose that may be adjusted"
      },
      {
        "name": "Cohort C",
        "type": "Experimental Arm",
        "description": "Participants receive subcutaneous ramucirumab alone or in combination with additional anti-cancer therapy"
      }
    ],
    "cohorts": [
      {
        "name": "Cohort A",
        "characteristic": "Initial cohort for PK and safety evaluation of SC ramucirumab"
      },
      {
        "name": "Cohort B",
        "characteristic": "Expansion cohort to investigate additional dosing regimens, comprising Sub-Cohorts B1, B2, and B3"
      },
      {
        "name": "Cohort C",
        "characteristic": "Cohort for SC ramucirumab alone or in combination with additional anti-cancer therapy"
      }
    ],
    "epochs": [
      {
        "name": "Screening",
        "description": "Screening period for eligibility assessment"
      },
      {
        "name": "Treatment",
        "description": "Multiple-dose treatment period with subcutaneous ramucirumab"
      },
      {
        "name": "Continued Access",
        "description": "Continued access period after study completion for eligible participants"
      }
    ]
  }
}